Cytiva Cardiomyocytes

Play this video
Cytiva Cardiomyocytes
Click to Playtemp-thumb

GE Healthcare

•  Cardiomyocytes are derived from human embryonic stem (hES) cells and could provide a biologically relevant alternative to current cell models and primary cells, for predictive toxicity testing...read more

Request Pricing





Receive your quote directly from GE Healthcare for Cytiva Cardiomyocytes

Description

 

•  Cardiomyocytes are derived from human embryonic stem (hES) cells and could provide a biologically relevant alternative to current cell models and primary cells, for predictive toxicity testing.
•  Highly characterized: Phenotype characterized by flow cytometry, subcellular imaging, and electrophysiology for both structural and functional markers, such as α-actinin, troponin I, α-MHC and electrical activity.

•  Functionally verified: Electrical properties verified using patch clamping for both action potential and individual ion channel currents

•  Representative myocyte population: Comprise ventricular, atrial, and nodal subtypes, the majority being ventricular myocytes.

•  Scalable: Available in quantities to match a range of applications, from manual patch clamping to high-content screening.

•  Cryopreserved for ease of use: Stable for at least 6 months when cryopreserved. High cell viability, at least 80%, after thawing. Ready-to- use on thawing, and can be maintained for at least 7 days once recovered into culture.

The availability of more biologically relevant and predictive assays and cell models is key to improving the success rate and reducing the cost of the drug discovery and development process. Such assays and models could facilitate the termination of unpromising compounds earlier in development and the engineering of potential drug molecules to remove toxic liabilities.

In drug discovery and development, up to three quarters of toxicity problems are not detected until preclinical or later stages, and cardiotoxicity is a common cause of drug safety liabilities and withdrawal of drugs during development. Industrial-scale production of cardiomyocytes could provide a readily available supply of cells for safety screening.

Feedback

Request info

To:GE Healthcare
From:
Please contact me / call me with the Cytiva Cardiomyocytes,

I am looking to purchase in /

.
About you

Write a review

Sharing your experience will help scientists like you. Achieve Reviewer Status and Win an iPad air (All reviews published will be entered into the next drawing on May 30th 2014).

  
Your Email

 



Ease of use

After sales services

Value for money

WATCH:
The benefits of becoming a reviewer
Share your opinions...()
HINTS & TIPS
Give reasons for the star ratings you have awarded for each area.
Would you recommend this to a colleague?
What would you like to have known about equipment and consumables before you purchased?



Why make an enquiry with SelectScience?

  • EASY It’s quick and simple to do
  • FAST Your enquiry will be delivered straight to the manufacturer
  • FREE You’re under no obligation
  • SECURE We only pass your details on to trusted suppliers at your request
  • SAVE TIME Submit your details once and make multiple enquiries
SelectScience Trusted Banner